
The purchase of German company Celesio has been announced by US pharmaceutical distributor McKesson. The deal is valued at more than $8 billion.
The combined company "will be one of the largest pharmaceutical wholesalers and providers of logistics and services in the healthcare sector worldwide," the German firm said in a statement.
Advertisement
The total transaction, including McKesson's takeover of Celesio's outstanding debt is valued at approximately $8.3 billion (6.3 billion euros, the statement added.
Both firms will keep their own separate brands.
The combined firm is expected to have annual revenue of more than $150 billion, employing some 81,500 people in 20 countries worldwide.
Earlier in the month, shares in McKesson rose sharply after the Wall Street Journal reported news of the buy-out.
Source: AFP
The combined firm is expected to have annual revenue of more than $150 billion, employing some 81,500 people in 20 countries worldwide.
Earlier in the month, shares in McKesson rose sharply after the Wall Street Journal reported news of the buy-out.
Source: AFP
Advertisement
Advertisement
|
Advertisement
Latest Corporate News

The first World Health Organisation (WHO)/ International Labour Organisation (ILO) joint global monitoring report shows that more action is needed to ensure healthier, safer, more resilient, and more social workplaces.

Successful career transitions could be possible when people leverage their existing skills in the new occupation. A new Artificial Intelligence tool helps employees figure out the right job according to their current skill set.

AI and big data rule the pharmaceutical sector by enhancing the drug development process and increasing the marketing and sales of drugs

Insurance companies in the US are working towards adding food to their coverage menu to improve the people's health under their coverage and cut hospital costs.

Pharmaceutical companies need to make strategic decisions that will provide financial benefit while showing strong commitment to global health and their patients during the pandemic.